Autres langues Assembly Biosciences, Inc.

Actions

ASMB

US0453962070

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
13,15 ^USD	+2,65%		+3,95%	+33,62%

28/03	Assembly Biosciences, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
19/01	Un initié d'Assembly Biosciences a acheté des actions pour une valeur de 511 264 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights	28/03
Assembly Biosciences Announces Effective Date of Reverse Stock Split	08/02
Assembly Biosciences Announces Effective Date of Reverse Stock Split	08/02
Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing	19/01
Assembly Biosciences, Inc. Provides Anticipated Development Milestones for 2024	04/01
Assembly Biosciences Provides Anticipated Development Milestones for 2024	04/01
Assembly Biosciences Provides Anticipated Development Milestones for 2024	04/01
Assembly Biosciences, Inc. Appoints Tomas Cihlar to Serve on the Board	07/12
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	10/11
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	10/11
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	10/11
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	10/11
Assembly Biosciences: Q3 Earnings Snapshot	08/11
Assembly Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates	08/11
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	08/11
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	08/11
Assembly Biosciences, Inc. Appoints Anuj Gaggar as Chief Medical Officer	08/11
Nano-Cap Stock Momentum Watchlist (SING, MGRX, ICU, ASMB)	20/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Assembly Biosciences, Inc.

Actions

ASMB

US0453962070

Autres langues

Filtres